Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Feb 28;9:856064. doi: 10.3389/fmolb.2022.856064

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Zhu, Chen, Kong, Wang, Fang, Li and Wang.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

DFS and OS based on SIRI scores of patients with breast cancer of different pathological stage. DFS and OS based on SIRI scores of patients with breast cancer of different pathological stage. (A) Kaplan-Meier analysis of DFS for the SIRI of patients with early breast cancer. (B) Kaplan-Meier analysis of OS for the SIRI of patients with early breast cancer. (C) Kaplan-Meier analysis of DFS for the SIRI of patients with advanced breast cancer. (D) Kaplan-Meier analysis of OS for the SIRI of patients with advanced breast cancer. (E) Kaplan-Meier analysis of DFS for the SIRI of patients with early breast cancer (NACT group). (F) Kaplan-Meier analysis of OS for the SIRI of patients with early breast cancer (NACT group). (G) Kaplan-Meier analysis of DFS for the SIRI of patients with advanced breast cancer (NACT group). (H) Kaplan-Meier analysis of OS for the SIRI of patients with advanced breast cancer (NACT group). (I) Kaplan-Meier analysis of DFS for the SIRI of patients with early breast cancer (non-NACT group). (J) Kaplan-Meier analysis of OS for the SIRI of patients with early breast cancer (non-NACT group). (K) Kaplan-Meier analysis of DFS for the SIRI of patients with advanced breast cancer (non-NACT group). (L) Kaplan-Meier analysis of OS for the SIRI of patients with advanced breast cancer (non-NACT group).